Novel approaches to treating cancer rely on an understanding of how we can recruit and activate the immune system to target cancer cells. Our researchers are investigating the fundamental immunological processes involved in cancer cell detection and clearance and exploring how immunodeficiency contributes to cancer progression. We are studying the complex tug-of-war between cancer cells and the immune system, including how cancer cells can release chemical signals that create an immunosuppressive tumor microenvironment, downregulate antigen presentation to evade immune surveillance, and undergo changes in gene expression to support unchecked growth and proliferation. We hope to lay the groundwork for new cell therapies, antibodies, vaccines, and other immunotherapies that can restore, enhance, and direct the immune response to treat a range of intractable cancers.
Faculty